AJP - Regu Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 275: R56-R62, 1998;
0363-6119/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikezaki, H.
Right arrow Articles by Rubinstein, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikezaki, H.
Right arrow Articles by Rubinstein, I.
Vol. 275, Issue 1, R56-R62, July 1998

Vasodilation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster cheek pouch

Hiroyuki Ikezaki, Sudhir Paul, Hayat Alkan-Önyüksel, Manisha Patel, Xiao-Pei Gao, and Israel Rubinstein

Departments of Medicine and Pharmaceutics and Pharmacodynamics, University of Illinois at Chicago, and West Side Department of Veterans Affairs Medical Center, Chicago, Illinois 60612; and Department of Anesthesiology, University of Nebraska Medical Center, Omaha, Nebraska 68198

The purpose of this study was to determine whether a monoclonal anti-vasoactive intestinal peptide (VIP) antibody, which binds VIP with high affinity and specificity and catalyzes cleavage of the peptide in vitro, attenuates VIP vasorelaxation in vivo and, if so, whether insertion of VIP on the surface of sterically stabilized liposomes (SSL), which protects the peptide from trypsin- and plasma-catalyzed cleavage in vitro, curtails this response. Using intravital microscopy, we found that suffusion of monoclonal anti-VIP antibody (clone c23.5, IgG2ak), but not of nonimmune antibody (myeloma cell line UPC10, IgG2ak) or empty SSL, significantly attenuates VIP-induced vasodilation in the in situ hamster cheek pouch (P < 0.05). By contrast, anti-VIP antibody has no significant effects on vasodilation elicited by isoproterenol, nitroglycerin, and calcium ionophore A-23187, agonists that activate intracellular effector systems in blood vessels that mediate, in part, VIP vasoreactivity. Suffusion of VIP on SSL, but not of empty SSL, restores the vasorelaxant effects of VIP in the presence of anti-VIP antibody. Collectively, these data suggest that VIP catalysis by high affinity and specific VIP autoantibodies displaying protease-like activity constitutes a novel mechanism whereby VIP vasoreactivity is regulated in vivo.

microcirculation; neuropeptide; autoimmunity; catalysis; sterically stabilized liposomes


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
T. Tsueshita, S. Gandhi, H. Onyuksel, and I. Rubinstein
Phospholipids modulate the biophysical properties and vasoactivity of PACAP-(138)
J Appl Physiol, October 1, 2002; 93(4): 1377 - 1383.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. Ikezaki, M. Patel, H. Onyuksel, S. R. Akhter, X.-P. Gao, and I. Rubinstein
Exogenous calmodulin potentiates vasodilation elicited by phospholipid-associated VIP in vivo
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1359 - R1365.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online